Millions in Africa and the rest of the developing world suffer from HIV/AIDS, malaria, and tuberculosis. What is the best way to treat them? Since President George W. Bush's pledge of $15 billion to fight these diseases, controversy has developed over strategies and methods. Last month at a conference in Botswana, delegates wrestled with the issue of fixed-dose combinations of anti-retroviral drugs, which have not been approved by the Food and Drug Administration but were "pre-qualified" by the World Health Organization. Are such drugs safe? Or does their use risk the development of new resistant strains of HIV? Activists have accused drug companies, with the support of the Bush administration, of trying to block the use of cheaper generics, but new research indicates that only a small fraction of drugs in the developing world is patented. This conference will focus on ways that policymakers should confront the obstacles to treating pandemic diseases in the developing world.
What's new on AEI
|In year four of Dodd-Frank, over-regulation is getting old|
|Halbig v. Burwell: A stunning rebuke of a lawless and reckless administration|
|Beware all the retirement 'crisis' reports|
|Cut people or change how they're paid|
Please join us for a broader exploration of targeted interventions that provide real promise for reducing health disparities, limiting or delaying the onset of chronic health conditions, and improving the performance of the US health care system.
Join us for a panel discussion that seeks to comprehend the comprehensives and to determine the role these schools play in the nation’s college completion agenda.
Please join AEI’s Center for Internet, Communications, and Technology Policy for a conference to address key steps we can take, as members of the global community, to maintain a free Internet.
Please join us as House Budget Committee Chairman Paul Ryan (R-WI) unveils a new set of policy reforms aimed at reducing poverty and increasing upward mobility throughout America.
We welcome you to join us at AEI as POLITICO’s Ben White moderates a lively debate between Tim Carney, one of the bank’s fiercest critics, and Tony Fratto, one of the agency’s staunchest defenders.